AbbVie Inc. is 209.6x more valuable than OCULAR THERAPEUTIX, INC by market capitalization ($399.47 B vs $1.91 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | OCUL | ABBV |
|---|---|---|
| Market cap | $1.91 B | $399.47 B |
| US-listed rank | #2122 | #28 |
| Revenue (latest FY) | $51.95M | $61.16B |
| Net income (latest FY) | -$265.94M | $4.23B |
| Net margin | -511.9% | 6.9% |
| P/E (trailing FY) | - | 94.5 |
| SEC filings | 827 | 1,008 |
AbbVie Inc. is 209.6x more valuable than OCULAR THERAPEUTIX, INC by market capitalization ($399.47 B vs $1.91 B).
In their latest fiscal years, OCULAR THERAPEUTIX, INC reported $51.95M in revenue while AbbVie Inc. reported $61.16B.
Full pages: OCULAR THERAPEUTIX, INC and AbbVie Inc., or browse the full rankings.